Publications

Steffens MS, Bolsewicz KT, King C, Bullivant B, Abdi I, Beard F. Australian parents' experiences with adolescent age-based vaccinations during the COVID-19 pandemic. Vaccine. 2024;43:126498. doi: 10.1016/j.vaccine.2024.126498 (Epub). [Full text]

Clark K, Crooks K, Jeyanathan B, Ahmed F, Kataquapit G, Sutherland C, Tsuji LJ, Moriarity RJ, Spence ND, Sekercioglu F, Liberda EN, Charania NA.. Highlighting models of Indigenous leadership and self-governance for COVID-19 vaccination programmes. AlterNative: An International Journal of Indigenous Peoples 2024. doi:10.1177/11771801241235418 (Epub). [Abstract]

Ong N, Brogan D, Lucien A, Wolman S, Campbell D, Deng L, Koirala A, Garg P, Sharma K. The development and evaluation of a vaccination pathway for children with intellectual and developmental disability and needle fear. Paediatric and Neonatal Pain 2023;6:1-9. doi: 10.1002/pne2.12103. [Full text]

Mazzocato P, Leder K, Deng L, Britton PN. Travel-associated illness in children in pre-pandemic Western Sydney, 2018-2020. Public Health Research and Practice 2024;34:3432422. doi: 10.17061/phrp3432422. [Full text]

Patel C, Vette K, Dalton L, Dey A, Hendry A, Hull B, McIntyre P, Macartney K, Beard F. Assessment of the first 5 years of pharmacist-administered vaccinations in Australia: learnings to inform expansion of services. Public Health Research and Practice 2024;34:3432420. doi: 10.17061/phrp3432420. [Full text]

Tinessia A, Clark K, Randell M, Leask J, King C. Strategies to address COVID-19 vaccine hesitancy in First Nations peoples: a systematic review. Global Health Action 2024;17:2384497. doi: 10.1080/16549716.2024.2384497 (Epub) . [Full text]

Loe MW, Soenong H, Lee E, Li-Kim-Moy J, Williams PC, Yeo KT. Nirsevimab: alleviating the burden of RSV morbidity in young children. Journal of Paediatrics and Child Health 2024. doi: 10.1111/jpc.16643 (Epub) . [Full text]

McDonald E, Pittet LF, Barry SE, Bonten M, Campbell J, Croda J, Croda MG, Dalcolmo MP, Davidson A, de Almeida E Val FF, Dos Santos MG, Gardiner MK, Gell MG, Gwee A, Krastev MA, Lacerda MVG, Lucas M, Lynn DJ, Manning L, McPhate MN, Perrett KP, Post JJ, Prat-Aymerich C, Quinn MLE, Richmond PC, Wood NJ, Messina NL, Curtis N; BRACE Trial Consortium Group. Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial. Journal of Infection 2024:106267. doi: 10.1016/j.jinf.2024.106267 (Epub). [Full text]

Reynolds R, Tay E, Dymock M, Deng L, Glover C, Lopez LK, Huang YA, Cashman P, Leeb A, Marsh JA, Snelling T, Wood N, Macartney K. Short-term active safety surveillance of the Spikevax and Nuvaxovid priming doses in Australia. Vaccines 2024; 12:971. doi: 10.3390/vaccines12090971 (Epub). [Full text]

Salter SM, Li D, Trentino K, Nissen L, Lee K, Orlemann K, Peters I, Murray K, Leeb A, Deng L. Safety of four COVID-19 vaccines across primary doses 1, 2, 3 and booster: a prospective cohort study of Australian community pharmacy vaccinations. Vaccines 2022;10:2017. doi: 10.3390/vaccines10122017. [Full text]